Mink Therapeutics Inc Strategic Asset Allocation Index
Mink Therapeutics Inc strategic asset allocation index. Mink Therapeutics Inc (INKT) has a Strategic Asset Allocation Index of 11.9% as of September 2022. Strategic assets (PP&E of $803.13K plus long-term investments of $-) total $803.13K, measured against net assets of $6.76 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Mink Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Mink Therapeutics Inc (2021–2021)
Strategic asset allocation index of Mink Therapeutics Inc from 2021 to 2021. This chart shows how Mink Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the index stands at 11.9%, representing strategic assets of $803.13K against net assets of $6.76 Million USD. Check INKT tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Mink Therapeutics Inc Strategic Asset Allocation Index by Year (2021–2021)
Mink Therapeutics Inc strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Mink Therapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Mink Therapeutics Inc market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 2.6% | $606.60K | $606.60K | $- | $23.78 Million | — |